1Stern DF, Heffernan PA, Wenberg RA. p185, a product of the neu proto- oneogene,is a reeeptorlike protein associated with tyrosine kinase activity[J]. Mol Cell Biol, 1986,6 (5) : 1729-1740. 被引量：1
2Essapen S,Thomas H, Green M,et al. The expression and prognostic sig- nificance of HER-2 in eolorectal cancer and its relationship with elinieo- pathological parameters [J]. Int J Oncol, 2004,24 (2) : 241-248. 被引量：1
3Half E, Broaddus R, Danenberg KD, et al. HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tu- mors [J]. Int J Cancer,2004,108(4) :540-548. 被引量：1
4Pohl M, Strieker I, Schoeneck A, et al. Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo[J]. J Cancer Res Clin Onco1,2009,135 (10) : 1377-1386. 被引量：1
5Vogel CL, Cobleigh MA,Tripathy D, et al. Efficacy and safety of trastuzu- mab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer[J]. Clin Oncol, 2002,20 (3) : 719-726. 被引量：1
6Riemer AB, Klinger M,Wagner S, et al. Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/ neu[J]. J Immunol, 2004,173 ( I ) : 394-401. 被引量：1
7Marx AH, Burandt EC,Chosehzick M,et al. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers[J]. Hum Pathol, 2010,41 ( 11 ) : 1577-1585. 被引量：1
8Sabatier R,Finetti P,Cervera N ,et al. A gene expression signature identi- fies two prognostic subgroups of basal basal cancer[J]. Brest Cancer Res Treat ,2011,126(2) :407-420. 被引量：1
9Kops G J, de Ruiter ND,de Vries-Smits AM, et al. Direct control of the Forkhead transcription factor AFX by protein kinase B[J]. Nature, 1999, 398 (6728) : 630-634. 被引量：1
10Bergamaschi A,Kim YH,Wang P,et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological fea- tures and gene-expression subtypes of breast cancer[J]. Genes chromo- somes cancer, 2006,45 (11 ) : 1033-1040. 被引量：1
